14 Quantitative Coronary Angiography in the Interventional Cardiology Salvatore Davide Tomasello1, Luca Costanzo2 and Alfredo Ruggero Galassi1 1Department of Internal Medicine…

1. Gene Pyramiding to Improve Green Super Rice by Molecular Marker-assisted SelectionYuqing He National Key Laboratory of Crop Genetic Improvement, National Center of Crop…

Slide 1Dip.di SCIENZE CARDIOVASCOLARI POLICLINICO UMBERTO I Dip.di SCIENZE CARDIOVASCOLARI POLICLINICO UMBERTO I Impact of Thromboaspiration during Primary PCI on Microvascular…

Slide 1 Slide 2 CTO-DEFINITION 100% luminal diameter obstruction without flow in that segment of 3 or more months duration Presence of TIMI 0 flow within an occluded segment…

Slide 1A Prospective, Randomized, "All-Comers" Trial of Biodegradable Polymer-Coated Biolimus-Eluting Stents vs. Biocompatible Polymer-Coated Zotarolimus-Eluting…

Slide 1 Slide 2 Slide 3 “Real World”: SVG, De Novo or Restenotic Coronary Artery Lesions Chronic Stable Angina, Silent Ischemia, Acute Coronary Syndromes Vessel Diameters:…

1.Comparative genomics: What makes the enterobacterial plant pathogen Pectobacterium atrosepticum different to its animal pathogenic relatives? And other questions. Leighton…

1. STRATEGIES & PREVENTIONOF SLOW FLOW &NO-REFLOW PHENOMENONDR. RAHUL ARORAPDT CARDIOLOGY 2. OUTLINEINTRODUCTIONIMPORTANCEDEFINITIONHISTORICAL BACKGROUNDINCIDENCECLASSIFICATIONDIAGNOSISCLINICAL…

Slide 1M.Unverdorben; ACC March 2008 Martin Unverdorben Rotenburg/Fulda, Germany and Richmond, VA, USA Clinical Research Institute, Center for Cardiovascular Diseases On…

Slide 1 EXCELLA BD Randomized Trial 12-month Results Elixir Medical Confidential Ricardo Costa, MD On behalf of the EXCELLA BD Investigators Slide 2 Elixir Medical DESyne…